Clinical Trials Browser

Phase 2 × Hodgkin Disease × ofatumumab × Clear all

NCT01195766 2016-02-24

Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma

NCT01187303 2015-11-02

Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)

Phase 2 Completed

Hodgkin Disease